148 related articles for article (PubMed ID: 21538476)
1. Caspase-2 deficiency protects mice from diabetes-induced marrow adiposity.
Coe LM; Lippner D; Perez GI; McCabe LR
J Cell Biochem; 2011 Sep; 112(9):2403-11. PubMed ID: 21538476
[TBL] [Abstract][Full Text] [Related]
2. CCAAT/enhancer binding protein β-deficiency enhances type 1 diabetic bone phenotype by increasing marrow adiposity and bone resorption.
Motyl KJ; Raetz M; Tekalur SA; Schwartz RC; McCabe LR
Am J Physiol Regul Integr Comp Physiol; 2011 May; 300(5):R1250-60. PubMed ID: 21346244
[TBL] [Abstract][Full Text] [Related]
3. Osteoblast-Specific Overexpression of Human WNT16 Increases Both Cortical and Trabecular Bone Mass and Structure in Mice.
Alam I; Alkhouli M; Gerard-O'Riley RL; Wright WB; Acton D; Gray AK; Patel B; Reilly AM; Lim KE; Robling AG; Econs MJ
Endocrinology; 2016 Feb; 157(2):722-36. PubMed ID: 26584014
[TBL] [Abstract][Full Text] [Related]
4. The bone marrow microenvironment contributes to type I diabetes induced osteoblast death.
Coe LM; Irwin R; Lippner D; McCabe LR
J Cell Physiol; 2011 Feb; 226(2):477-83. PubMed ID: 20677222
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of PPARgamma prevents type I diabetic bone marrow adiposity but not bone loss.
Botolin S; McCabe LR
J Cell Physiol; 2006 Dec; 209(3):967-76. PubMed ID: 16972249
[TBL] [Abstract][Full Text] [Related]
6. Bisphosphonate treatment of type I diabetic mice prevents early bone loss but accentuates suppression of bone formation.
Coe LM; Tekalur SA; Shu Y; Baumann MJ; McCabe LR
J Cell Physiol; 2015 Aug; 230(8):1944-53. PubMed ID: 25641511
[TBL] [Abstract][Full Text] [Related]
7. Transgenic overexpression of tartrate-resistant acid phosphatase is associated with induction of osteoblast gene expression and increased cortical bone mineral content and density.
Gradin P; Hollberg K; Cassady AI; Lång P; Andersson G
Cells Tissues Organs; 2012; 196(1):68-81. PubMed ID: 22248481
[TBL] [Abstract][Full Text] [Related]
8. Low dose aspirin therapy decreases blood glucose levels but does not prevent type i diabetes-induced bone loss.
Coe LM; Denison JD; McCabe LR
Cell Physiol Biochem; 2011; 28(5):923-32. PubMed ID: 22178944
[TBL] [Abstract][Full Text] [Related]
9. Increased bone adiposity and peroxisomal proliferator-activated receptor-gamma2 expression in type I diabetic mice.
Botolin S; Faugere MC; Malluche H; Orth M; Meyer R; McCabe LR
Endocrinology; 2005 Aug; 146(8):3622-31. PubMed ID: 15905321
[TBL] [Abstract][Full Text] [Related]
10. Curcumin suppresses increased bone resorption by inhibiting osteoclastogenesis in rats with streptozotocin-induced diabetes.
Hie M; Yamazaki M; Tsukamoto I
Eur J Pharmacol; 2009 Oct; 621(1-3):1-9. PubMed ID: 19699734
[TBL] [Abstract][Full Text] [Related]
11. Wnt10b increases postnatal bone formation by enhancing osteoblast differentiation.
Bennett CN; Ouyang H; Ma YL; Zeng Q; Gerin I; Sousa KM; Lane TF; Krishnan V; Hankenson KD; MacDougald OA
J Bone Miner Res; 2007 Dec; 22(12):1924-32. PubMed ID: 17708715
[TBL] [Abstract][Full Text] [Related]
12. 2,3,7,8-Tetrachlorodibenzo-p-dioxin dose-dependently increases bone mass and decreases marrow adiposity in juvenile mice.
Fader KA; Nault R; Raehtz S; McCabe LR; Zacharewski TR
Toxicol Appl Pharmacol; 2018 Jun; 348():85-98. PubMed ID: 29673856
[TBL] [Abstract][Full Text] [Related]
13. Normal bone density obtained in the absence of insulin receptor expression in bone.
Irwin R; Lin HV; Motyl KJ; McCabe LR
Endocrinology; 2006 Dec; 147(12):5760-7. PubMed ID: 16973725
[TBL] [Abstract][Full Text] [Related]
14. ApoE gene deficiency enhances the reduction of bone formation induced by a high-fat diet through the stimulation of p53-mediated apoptosis in osteoblastic cells.
Hirasawa H; Tanaka S; Sakai A; Tsutsui M; Shimokawa H; Miyata H; Moriwaki S; Niida S; Ito M; Nakamura T
J Bone Miner Res; 2007 Jul; 22(7):1020-30. PubMed ID: 17388726
[TBL] [Abstract][Full Text] [Related]
15. Glycogen synthase kinase-3α/β inhibition promotes in vivo amplification of endogenous mesenchymal progenitors with osteogenic and adipogenic potential and their differentiation to the osteogenic lineage.
Gambardella A; Nagaraju CK; O'Shea PJ; Mohanty ST; Kottam L; Pilling J; Sullivan M; Djerbi M; Koopmann W; Croucher PI; Bellantuono I
J Bone Miner Res; 2011 Apr; 26(4):811-21. PubMed ID: 20939016
[TBL] [Abstract][Full Text] [Related]
16. Increased cathepsin K and tartrate-resistant acid phosphatase expression in bone of streptozotocin-induced diabetic rats.
Hie M; Shimono M; Fujii K; Tsukamoto I
Bone; 2007 Dec; 41(6):1045-50. PubMed ID: 17916452
[TBL] [Abstract][Full Text] [Related]
17. High-fat diet causes bone loss in young mice by promoting osteoclastogenesis through alteration of the bone marrow environment.
Shu L; Beier E; Sheu T; Zhang H; Zuscik MJ; Puzas EJ; Boyce BF; Mooney RA; Xing L
Calcif Tissue Int; 2015 Apr; 96(4):313-23. PubMed ID: 25673503
[TBL] [Abstract][Full Text] [Related]
18. Role of parathyroid hormone-related protein in the decreased osteoblast function in diabetes-related osteopenia.
Lozano D; de Castro LF; Dapía S; Andrade-Zapata I; Manzarbeitia F; Alvarez-Arroyo MV; Gómez-Barrena E; Esbrit P
Endocrinology; 2009 May; 150(5):2027-35. PubMed ID: 19196804
[TBL] [Abstract][Full Text] [Related]
19. Deletion of FoxO1, 3, and 4 in Osteoblast Progenitors Attenuates the Loss of Cancellous Bone Mass in a Mouse Model of Type 1 Diabetes.
Iyer S; Han L; Ambrogini E; Yavropoulou M; Fowlkes J; Manolagas SC; Almeida M
J Bone Miner Res; 2017 Jan; 32(1):60-69. PubMed ID: 27491024
[TBL] [Abstract][Full Text] [Related]
20. Altered bone development and turnover in transgenic mice over-expressing lipocalin-2 in bone.
Costa D; Lazzarini E; Canciani B; Giuliani A; Spanò R; Marozzi K; Manescu A; Cancedda R; Tavella S
J Cell Physiol; 2013 Nov; 228(11):2210-21. PubMed ID: 23606520
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
